EGF and breast cancer: Additionally, treatment of unmodified breast cancer cells (or cells expressing only WT PR-B) with EGF further implicated PR Ser294 phosphorylation (PR deSUMOylation) in transcriptional derepression of selected PR target genes (Figure 2).